A Phase IIa Study to Evaluate NBQ72S

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 22, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

February 28, 2027

Conditions

Breast Cancer

Interventions

DRUG

NBQ72S

Patients will receive the study drug every 28 days

Trial Locations (1)

RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors

lead

Nantong Bencao Quadriga Medical Technology Co. Ltd.

INDUSTRY